CSIMarket Company Name, Ticker, Customers, else..


Collegium Pharmaceutical inc   (NASDAQ: COLL)
Other Ticker:  
 

Collegium Pharmaceutical inc

COLL's Fundamental analysis



Looking into Collegium Pharmaceutical Inc growth rates, revenue grew by 22.75 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 1449

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.43 %

Collegium Pharmaceutical Inc 's net profit decreased by -91.28 % in first quarter of 2025 year on year, to $2 millions.

• More on COLL's Growth


Collegium Pharmaceutical Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Collegium Pharmaceutical Inc realized cash reduction of $ -3.43 per share in trailing twelve-month period.
Company
24.84
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


• More on COLL's Valuation
 
 Total Debt (Millions $) 838
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,478,374
 Net Income/Employee (TTM) $ 130,249
 Receivable Turnover (TTM) 2.29
 Tangible Book Value (Per Share $) -22.91

Collegium Pharmaceutical Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Collegium Pharmaceutical Inc realized cash outflow of $ -3.43per share in trailing twelve-month period.
Company
24.84
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.

Collegium Pharmaceutical Inc Price to Book Ratio is at 4.15 lower than Industry Avg. of 34.08. and higher than S&P 500 Avg. of 0.01

• More on COLL's Valuation

•  Market Capitalization (Millions $) 972
•  Shares Outstanding (Millions) 33
•  Employees 337
•  Revenues (TTM) (Millions $) 498
•  Net Income (TTM) (Millions $) 44
•  Cash Flow (TTM) (Millions $) -113
•  Capital Exp. (TTM) (Millions $) -2
•  Total Debt (Millions $) 838
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,478,374
•  Net Income/Employee(TTM) $ 130,249
•  Receivable Turnover Ratio (TTM) 2.29
•  Tangible Book Value (Per Share $) -22.91

•  Market Capitalization (Millions $) 972
•  Shares Outstanding (Millions) 33
•  Employees 337
•  Revenues (TTM) (Millions $) 498
•  Net Income (TTM) (Millions $) 44
•  Cash Flow (TTM) (Millions $) -113
•  Capital Exp. (TTM) (Millions $) -2


    COLL's Profitability Comparisons
Collegium Pharmaceutical Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.23 % from 220.45 % in IV. Quarter.

Collegium Pharmaceutical Inc net profit margin of 1.36 % is currently ranking no. 57 in Major Pharmaceutical Preparations industry, ranking no. 168 in Healthcare sector and number 2051 in S&P 500.


Profitability by Segment
Segment 1.36 %
Total 1.36 %



  Ratio
•   Capital Ratio (MRQ) 1.08
•  Total Debt to Equity (MRQ) 3.57
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.33
•  Inventory Turnover Ratio (TTM) 7.99



Collegium Pharmaceutical Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 12.23 % from 220.45 % in IV. Quarter.

Collegium Pharmaceutical Inc net profit margin of 1.36 % is currently ranking no. 57 in Major Pharmaceutical Preparations industry, ranking no. 168 in Healthcare sector and number 2051 in S&P 500.

• More on COLL's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com